Skip to main content
. Author manuscript; available in PMC: 2020 Mar 13.
Published in final edited form as: Lab Chip. 2019 Mar 13;19(6):993–1005. doi: 10.1039/c8lc01399c

Figure 4.

Figure 4.

Analysis of KRAS G12+ CRC patient plasma samples using our droplet PCR assay. a) Representative fluorescent microscope images of droplets following PCR from a Stage IIA cancer patient (i – BF, ii – fluorescent) and a control healthy patient (iii – BF, iv – fluorescent) (Scale bar = 500 μm). Positive droplets were defined as those with a signal-to-noise ratio (SNR) greater than 3.0 and then enumerated in group (b) or as individual patient (c). Y axis = number of detected droplets in 100 μl final volume.